These Three Toilets Detection Health Technologies Will Be Clinically Tested In The US, Israel And Japan

These Three Toilets Detection Health Technologies Will Be Clinically Tested In The US, Israel And Japan

Israeli digital health startup OutSense has been awarded a number of patents for key innovations in IoT technology, according to foreign media reports on 23 ekaina. The technology gains life-saving medical insights by analysing human excrement. Konpainiak hiru patente aurkeztu ditu bere mediku komuneko sentsorearen elementuak estaltzen dituztenak.

Three Toilets Detection Health Technologies

The first OutSense toilets detection health technologies is for the detection of blood hidden in the toilet bowl. This OutSense device uses reflected light from the toilet to determine the optical signature of hidden blood in faeces. Patents for this technology have been granted in the US, Europa, Japonia eta Txina.

A second toilets detection health technologies has been granted in Europe and applications for this patent are pending in other countries. It allows effective analysis of the many components of faeces and the spatial distribution of blood traces. On the basis of this analysis, OutSense-ren teknologiak traktu gastrointestinalean zehar odol-iturria identifikatu dezake.

A third patent is pending for a technology that detects the dehydrated composition of urine through the analysis of urine and faeces.

OutSense zuzendari Yfat Scialomen arabera, who predicts that “medikuntza digitalaren eztandarekin, this kind of monitoring will become the norm”, OutSense says that the technology already approved and pending approval will provide broad protection for a person’s health by non-invasively extracting faeces and hidden blood from the urine. Hidden blood is essential for detecting colorectal cancer, hesteetako hanturazko gaixotasuna eta gernu-traktuko infekzioak.

Its solution consists of a multispectral optical sensor, argi-iturri bat eta WiFi konexioa duen pantaila-gailu autonomo bat. The device scans human excrement, identifies the optical footprint of faecal and urine components, sends the data to an AI-based cloud analysis and then provides indications of various diseases with great precision.

OutSense has developed tools to diagnose abnormalities in human excreta. Laginatutako odoletik lortutako informazioa, odoljariotik kanporatze arteko denboraren analisi gehigarriarekin konbinatuta, odoljarioaren patologiaren xehetasunak ematen ditu. Its specific patterns can determine whether the bleeding is from a fissure or haemorrhoid, from a polyp, a tumour or from an ulcer.

At the beginning of June, OutSense-k jakinarazi zuen CommuniCare, baino gehiago dituen osasun-enpresa handi bat 90 healthcare facilities in the US, aurten hasiko da bere teknologia probatzen. Pilotu honetaz gain, OutSense also plans to conduct clinical trials in Israel and Japan.

Bisitatu Berri gehiago hemen Viga.cc Berriak